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Abstract
Introduction
To our knowledge, no study has determined whether 
smoking prevalence is higher among people with dis-
abilities than among people without disabilities across all 
U.S. states. Neither do we know whether people with dis-
abilities and people without disabilities receive the same 
quality of advice about tobacco-cessation treatment from 
medical providers.
Methods
We analyzed data from the 2004 Behavioral Risk Factor 
Surveillance System to estimate differences between 
people with and people without disabilities in smoking 
prevalence and the receipt of tobacco-cessation treatment 
advice from medical providers.
Results
We found that smoking prevalence for people with dis-
abilities was approximately 50% higher than for people 
without disabilities. Smokers with disabilities were more 
likely than smokers without disabilities to have visited a 
medical provider at least once in the previous 12 months 
and to have received medical advice to quit. More than 
40% of smokers with disabilities who were advised to 
quit, however, reported not being told about the types of 
tobacco-cessation treatment available.
Conclusion
Ensuring that people with disabilities are included in 
state-based smoking cessation programs gives states an 
opportunity to eliminate health disparities and to improve 
the health and wellness of this group. Ways to reduce 
unmet preventive health care needs of people with dis-
abilities include provider adoption of the Public Health 
Service’s clinical practice guideline and the provision of 
smoking cessation services that include counseling and 
effective pharmaceutical treatment.
Introduction
Disability affects more than 50 million Americans, and 
annual health care expenditures and productivity losses 
for people with disabilities exceed $300 billion (1). A com-
pounding factor in this public health issue is that smok-
ing prevalence is higher among people with disabilities 
than among people without disabilities, as was found in 
one population-based study of adults in Massachusetts 
(2). Other research indicates that the prevalence of 
cigarette smoking is higher in some socioeconomic and 
demographic groups than in others and that not all 
populations, including people with disabilities, receive 
the same level of preventive health care (1,3). To our 
knowledge, no study has determined whether the find-
ings in the Massachusetts study extend to other states. 
From a policy standpoint, identifying disparities in smok-
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ing prevalence is important to determining how best to 
direct resources to reduce these disparities. Moreover, 
reducing health disparities is especially relevant, given 
the recent publication of the 2005 Surgeon General’s Call 
to Action To Improve the Health and Wellness of People 
with Disabilities (4).
Health care costs for people with disabilities and for 
the elderly account for a large proportion of Medicare 
and Medicaid expenditures (5). In 2001, approximately 
40% of Medicare expenditures were for inpatient hospital 
care for these groups (6). Expenses related to the chronic 
conditions of 5% of Medicare fee-for-service beneficiaries 
accounted for 34% of the expense for all beneficiaries. 
Although people who have a disability or are elderly make 
up one-quarter of Medicaid’s recipients, they accounted for 
approximately 70% of the program’s expenditures in 2004 
(7). Long-term care for people whose disability prevents 
them from living independently accounted for approxi-
mately one-third of Medicaid spending in 2004.
According to the Congressional Budget Office, Medicare 
and Medicaid expenditures may grow at unsustainable 
rates (6). Chronic disease management has been suggest-
ed as a means of containing the growth rate in Medicare 
costs, and the National Governors Association recom-
mends that states consider health promotion activities to 
prevent chronic disease as a means of controlling Medicaid 
expenditures (8).
Smoking, which harms nearly every organ of the body 
and causes many cancers, cardiovascular diseases, and 
respiratory illnesses, is the leading preventable cause of 
morbidity and mortality and results in approximately 
440,000 deaths annually in the United States (9,10). 
Healthy People 2010 (1) recommends that states target 
tobacco-related illnesses through tobacco-control programs 
to reduce disease, disability, and death related to tobacco 
use by preventing the initiation of tobacco use, promoting 
cessation, eliminating exposure to secondhand smoke, and 
identifying and working to eliminate disparities in tobacco 
use among different populations. The Healthy People 
2010 objectives are identical to several of the National 
Governors Association recommendations designed to 
reduce tobacco use.
The purpose of our study was to identify disparities in 
current smoking prevalence among people with and people 
without disabilities and to estimate the prevalence and 
assess the quality of advice on tobacco-cessation treatment 
given by medical providers to this population by state.
Methods
We used data from the 2004 Behavioral Risk Factor 
Surveillance System (BRFSS) from the 50 U.S. states; 
the District of Columbia; and the two U.S. territories for 
which data were available, Puerto Rico and the U.S. Virgin 
Islands. The BRFSS is a state-based, random-digit–dialed, 
telephone survey of the U.S. civilian noninstitutionalized 
population aged 18 years or older (11,12). Conducted by all 
states with assistance from the Centers for Disease Control 
and Prevention (CDC), the survey is completed by trained 
interviewers who collect comprehensive data on demo-
graphics, health, behavioral health risks, and disease pre-
vention behaviors. The data are used to quantify state-level 
prevalences of major behavioral health risks associated 
with premature morbidity and mortality and to evaluate 
their impact. In turn, this information is used in the devel-
opment of state health promotion and disease prevention 
programs. A detailed description of the compilation and use 
of BRFSS data is available at www.cdc.gov/brfss/.
Definitions 
Disability
The 2004 BRFSS questionnaire included two questions 
on disability screening: “Are you limited in any way in 
any activities because of physical, mental, or emotional 
problems?” and “Do you now have any health problem 
that requires you to use special equipment, such as a 
cane, a wheelchair, a special bed, or a special telephone?” 
We defined respondents as having a disability if they 
answered yes to either of these questions. Data on people 
who did not respond, refused to respond, or whose respons-
es were missing were excluded from the analysis.
Current smoking
The survey used two questions to determine cigarette 
use: “Have you smoked at least 100 cigarettes in your 
entire life?” and “Do you now smoke cigarettes every day, 
some days, or not at all?” We defined current smokers as 
people who reported smoking at least 100 cigarettes dur-
ing their lifetime and who currently smoke every day or 
some days. Data on people who did not respond, refused to 
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respond, or whose responses were missing were excluded 
from the analysis.
Smoking cessation treatment advice
Each year, states may choose to incorporate optional 
modules of questions on specific topics into their BRFSS 
survey. In 2004, 20 states and the U.S. Virgin Islands 
included questions from the tobacco-cessation module. 
Respondents were asked, “In the past 12 months, how 
many times have you seen a doctor, nurse, or other 
health professional to get any kind of care for yourself?” 
Respondents who had seen a doctor were also asked, “In 
the past 12 months, on how many visits were you advised 
to quit smoking by a doctor or other health care provider?” 
We defined people as having received advice to quit smok-
ing if they reported having received such advice on at least 
one visit. Data on people who did not respond, refused to 
respond, or whose responses were missing were excluded 
from the analysis.
Respondents who had seen a health care provider in 
the previous 12 months were also asked, “On how many 
visits did your doctor, nurse, or other health professional 
recommend or discuss medication to assist you with 
quitting smoking, such as nicotine gum, patch, nasal 
spray, inhaler, lozenge, or prescription medication such as 
Wellbutrin/Zyban/Bupropion?” and “On how many visits 
did your doctor or health provider recommend or discuss 
methods and strategies other than medication to assist 
you with quitting smoking?” We defined respondents as 
having been counseled on smoking cessation treatment 
options if they reported receiving this information on 
at least one visit. Data on people who did not respond, 
refused to respond, or whose responses were missing were 
excluded from the analysis.
Analysis
We used a SAS-callable version of SUDAAN (Research 
Triangle Institute, Research Triangle Park, North 
Carolina) to obtain state-level prevalences of disability, 
current smoking, and advice given by a medical provider 
on smoking cessation and on medication to assist in quit-
ting. For estimates of standard errors and 95% confidence 
intervals (CIs), the data were weighted to account for 
differential probability of selection and, in part, to adjust 
for nonresponse. Estimates were age-adjusted to the 
2000 U.S. standard population (13,14). Estimates were 
not reported if the number of responses to questions on 
smoking status, smoking cessation advice, and treatment 
options were less than 50 or the related CI half-width was 
greater than 10. Hawaii was not included in our analysis, 
because data were not available for 2004.
Results
In 2004, the median age-adjusted prevalence of current 
cigarette smoking in the 49 states for which data were 
available and in the District of Columbia, Puerto Rico, and 
the U.S. Virgin Islands was higher for people with disabili-
ties (median = 29.9%) than for people without disabilities 
(median = 19.8%) (Table 1). Smoking prevalence for people 
with disabilities was highest in Delaware (39.4%; 95% 
CI, 33.4–45.4) and lowest in Puerto Rico (16.5%; 95% CI, 
11.9–21.1). In a comparison of smoking among people with 
and without disabilities, Delaware had the highest differ-
ence in smoking prevalence (17.1 percentage points), and 
Puerto Rico had the lowest (4.3 percentage points).
For the 20 states that administered the smoking cessa-
tion module in 2004, we calculated both age-adjusted and 
unadjusted estimates (Table 2). Although we present both 
sets of data in the table for comparison, we discuss only 
the age-adjusted estimates. According to these estimates, 
smokers with disabilities were more likely (median = 
87.2%) than smokers without disabilities (median = 75.5%) 
to report having visited a health care provider at least once 
in the previous 12 months. Of this group, smokers with 
disabilities were more likely (median = 70.7%) than smok-
ers without disabilities (median = 66.9%) to have been 
advised by their provider about smoking cessation. And of 
smokers receiving such advice, those with disabilities were 
more likely (59.6%) than those without disabilities (51.0%) 
to have discussed medications and other methods to quit 
smoking with their providers.
Discussion
For the first time since the inception of national health 
objectives, Healthy People 2010 includes a goal specifically 
for people with disabilities (1). That goal is to promote 
the health of people with disabilities, prevent secondary 
conditions, and reduce health disparities. The chapter 
on tobacco use in Healthy People 2010 sets the year 2010 
target for cigarette smoking prevalence at 12% — a 50% 
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reduction in prevalence — and points out that current 
levels of cigarette use are highest among men and cer-
tain racial and ethnic populations, including American 
Indians and Alaskan Natives (1). Our findings reveal 
a substantially higher prevalence of cigarette smoking 
among people with disabilities than among people without 
disabilities, indicating that people with disabilities must 
be included with other minority populations as a target 
group in tobacco-cessation activities if states hope to meet 
the Healthy People 2010 smoking prevalence target.
Comprehensive tobacco control, including health insur-
ance coverage for cessation counseling and pharmaceutical 
treatments, is effective in preventing and reducing tobacco 
use (15-18). When health care providers must address 
multiple acute health problems, however, their time spent 
on discussing preventive treatment options with patients 
may be less than optimal, which may lead to reduced qual-
ity of care for people with disabilities (19). The underuse 
of preventive health care for people with disabilities may 
also be a result of patient-provider miscommunication, 
lack of patient adherence, patient access problems (e.g., 
transportation), lack of provider training, office staff’s lack 
of knowledge on how to accommodate people with dis-
abilities, poor specialist care coordination, and insufficient 
financial incentives (19-31).
People with disabilities are less likely than people with-
out disabilities to receive preventive health care and so are 
more susceptible to illness and disease (19-31). The result 
may be a decline in health, which can lead to reduced lev-
els of activity and increased functional dependence. The 
earlier study in Massachusetts (2) suggests that smokers 
with disabilities are more likely than smokers without 
disabilities to receive medical advice to quit. Information 
is not available, however, on whether the quality of advice 
given to these two groups is comparable. Although our 
findings concur with the Massachusetts study, they also 
reveal that more than 40% of smokers with disabilities 
who were advised to quit did not receive information about 
medication and other tobacco-cessation treatments.
To improve the health of people with disabilities, the 
50 states, the District of Columbia, and the U.S. ter-
ritories should provide coverage under Medicaid for all 
recommended tobacco-dependence treatments (32). Aside 
from the advantages to public health, reducing smok-
ing prevalence among people with disabilities is fiscally 
prudent. Disability is associated with poverty (33), and 
smoking rates of participants in state-funded programs, 
such as Medicaid, that serve these people are 50% higher 
than those for the U.S. adult population (32,34). Medicaid 
expenditures attributable to smoking exceed $12 billion 
annually (35), a cost that could be cut if states invested in 
smoking cessation efforts that reduced the prevalence of 
smoking (36).
State revenues from tobacco settlement money and tobac-
co excise taxes totaled $21.2 billion in fiscal year 2006 (37). 
Despite this income stream and reported increases in state 
smoking cessation expenditures associated with reductions 
in smoking prevalence (36), the amount of money that 
states spent on tobacco control in 2006 totaled only $551 
million, approximately one-third of the minimum amount 
recommended by CDC to prevent and reduce tobacco use 
and minimize health-related harm and cost (37). For fiscal 
year 2007, only three states — Colorado, Delaware, and 
Maine — achieved CDC’s recommended minimum per 
capita investment for tobacco-control programs (38). To 
effectively prevent and reduce tobacco use among people 
with disabilities, states will need to promote health system 
changes that reduce barriers limiting the ability of these 
people to access and use preventive health care. Efforts 
and funding to reduce disparities in smoking prevalence 
among people with disabilities must be increased if more 
states are to achieve the Healthy People 2010 goal of 
reducing smoking prevalence to 12% or less.
To our knowledge, our study is the first to quantify state-
level differences in smoking prevalence among people with 
and without disabilities and to identify opportunities to 
improve the quality of tobacco-cessation counseling given 
to people with disabilities. Despite this contribution, our 
study has several limitations. First, the BRFSS survey 
may understate the true prevalence of disability, because 
it excludes the institutionalized population, people in 
households without telephones, and people whose disabil-
ity prevents them from answering the telephone. Second, 
BRFSS data are based on self-reports and have not been 
validated. Third, BRFSS questions used to define disabil-
ity do not indicate type or severity. Without this informa-
tion, our results may be conservative, given that certain 
types (e.g., psychiatric conditions) and levels of severity of 
disability are associated with the increased likelihood of 
smoking and with greater nicotine dependence (39-42).
Fourth, other factors, including sociodemographic char-
acteristics such as poverty, might be associated with 
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smoking (36). Although the BRFSS does not identify 
respondents who live in poverty, it does report income 
ranges. In 2004, 5.3% of BRFSS respondents reported 
income below $10,000. Using this income threshold as a 
proxy for poverty, we found that smoking prevalence was 
14.9 percentage points higher for impoverished respon-
dents with disabilities than for impoverished respondents 
without disabilities (36.7% vs 22.6%; P < .01). Smoking 
prevalence was 4.3 percentage points higher for respon-
dents with disabilities with annual incomes of $10,000 
or more than their counterparts with this level of income 
(24.4% vs 20.1%; P < .01). When we adjusted these esti-
mates for age, the disparities were larger. We also reex-
amined, by poverty status, the state-level differences in 
the frequency and quality of tobacco-cessation treatment 
advice given by health care providers to people with and 
without disabilities. We found that impoverished smok-
ers with disabilities were more likely than impoverished 
smokers without disabilities to receive medical advice to 
quit and that providers were more likely to discuss medi-
cation and other tobacco-cessation treatments with these 
patients. Accounting for the potential confounding effects 
of other factors associated with smoking using multivari-
ate analytical techniques is a direction for future work.
Finally, characterizing the causality between smoking 
and disability was beyond the scope of this analysis. This 
information would be valuable because smoking rates are 
higher for people with disabilities than for people without 
disabilities, and people with disabilities who smoke increase 
their risk of developing chronic conditions that might 
adversely interact with their primary disabling condition.
In the belief that reducing rates of debilitating chronic 
diseases may slow the growth rate in health care expendi-
tures, interest has focused on reducing disparities in the 
quality of preventive health care. This work has centered 
on identifying and eliminating racial and ethnic differ-
ences, but people with disabilities are another vulnerable 
population whose preventive health care needs often go 
unmet. Disparities in smoking prevalence and the use of 
preventive medical services put people, particularly those 
with disabilities, at risk for declining health, decreased 
levels of activity, and increased functional dependence. 
Health promotion activities to prevent or reduce the onset 
of chronic diseases among people with disabilities may 
slow the growth rate in health care costs by reducing 
hospital admissions and delaying or preventing nursing 
home entry.
Ensuring that people with disabilities are included in 
state-based smoking cessation programs gives states an 
opportunity to eliminate disparities and improve the qual-
ity of preventive health care for people with disabilities. 
This action would meet the Healthy People 2010 objectives 
on disability and tobacco use and the recommendations of 
the National Governors Association (7) and could reduce 
the growth rate in health care expenditures. Ways to 
reduce unmet preventive health care needs of people with 
disabilities include provider adoption of the Public Health 
Service’s clinical practice guideline and the provision of 
smoking cessation services that include counseling and 
effective pharmaceutical treatment. Given the barriers 
that limit access to and use of preventive health care ser-
vices, the 1-800-QUITNOW National Network of Tobacco 
Cessation Quitlines and the www.smokefree.gov Web site 
may be particularly important in assisting people with dis-
abilities to quit smoking.
The inclusion of people with disabilities in smoking ces-
sation programs will require overcoming the many barriers 
to preventive care that they experience. For most states, 
this action will require reversing recent trends and follow-
ing the examples set by Colorado, Delaware, and Maine by 
funding at least the minimum per capita amount that CDC 
recommends for tobacco-control programs. In the absence of 
meeting the CDC recommendation, the preventive health 
care needs of these people will continue to go unmet.
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Table 1. Smoking Prevalence Among Adultsa, by Disability Status, Behavioral Risk Factor Surveillance System, 49 Statesb, 
District of Columbia, Puerto Rico, and the U.S. Virgin Islandsc, 2004
State, District, Territory
With Disability Without Disability
Unadjusted 
% (95% CI)
Age-Adjusted 
% (95% CI)
Unadjusted 
% (95% CI)
Age-Adjusted 
% (95% CI)
Alabama 29.7 (26.1-.) 4. (29.-9.1) 2.7 (21.7-2.7) 2. (21.-2.)
Alaska 29.7 (2.9-.) 1.9 (2.4-8.4) 2. (20.7-2.9) 21.7 (19.2-24.2)
Arizona 2.7 (19.4-2.0) 0.2 (21.9-8.) 17.1 (14.8-19.4) 16.8 (14.6-19.0)
Arkansas 27. (24.0-0.6) 2.1 (27.-6.7) 24.6 (22.7-26.) 24. (22.-26.1)
California 18.2 (1.0-21.4) 22. (18.-26.7) 14.1 (12.7-1.) 1.6 (12.2-1.0)
Colorado 2.8 (20.0-27.6) 28. (2.2-.4) 19. (17.8-21.2) 18.6 (17.0-20.2)
Connecticut 22.4 (19.-2.) 27.9 (2.6-2.2) 17.1 (1.7-18.) 17.0 (1.6-18.4)
Delaware .0 (28.2-7.8) 9.4 (.4-4.4) 22.9 (20.8-2.0) 22. (20.-24.)
Florida 2.9 (20.6-27.2) 0.8 (26.-.) 19.2 (17.-20.9) 19.6 (17.9-21.)
Georgia 2.2 (19.8-26.6) 26.4 (22.0-0.8) 19. (17.-21.1) 18.6 (16.9-20.)
Idaho 2.8 (20.8-26.8) 28. (24.-2.) 16.0 (14.6-17.4) 1. (14.1-16.9)
Illinois 2. (19.7-27.) 28.6 (2.7-.) 21.9 (20.1-2.7) 21. (19.6-2.0)
Indiana 29. (26.2-2.4) .4 (1.6-9.2) 2.9 (22.-2.) 2. (22.0-24.6)
Iowa 22. (19.1-2.) 29. (24.4-4.6) 20.7 (19.2-22.2) 20. (19.0-22.0)
Kansas 2.9 (21.6-26.2) 29.0 (2.7-2.) 19.1 (17.9-20.) 18.6 (17.-19.7)
Kentucky 1. (28.4-4.6) .1 (1.1-9.1) 26.7 (24.-28.9) 26.0 (2.9-28.1)
Louisiana 29.4 (26.-2.) .6 (0.0-7.2) 22.2 (20.9-2.) 21.6 (20.4-22.8)
Maine 2.8 (21.7-29.9) 0.2 (24.9-.) 19.7 (17.8-21.6) 19.9 (18.0-21.8)
Maryland 24.9 (20.-29.) 28.6 (22.7-4.) 18.2 (16.4-20.0) 17.7 (16.0-19.4)
Massachusetts 24.0 (21.2-26.8) 28.2 (24.-1.9) 17. (16.1-18.9) 17.2 (1.9-18.)
Michigan 27.4 (24.1-0.7) 2.6 (28.-6.9) 22.2 (20.-2.9) 21.6 (20.0-2.2)
Minnesota 21. (18.-24.1) 24.9 (21.-28.) 20. (18.8-22.2) 19.7 (18.1-21.)
Mississippi 28.7 (2.8-1.6) . (29.-7.1) 2.1 (21.4-24.8) 22.4 (20.8-24.0)
Missouri 2. (22.-28.7) 29.9 (2.-4.) 2.7 (21.7-2.7) 2.0 (21.1-24.9)
Montana 2.7 (20.-26.9) 26.6 (22.-0.9) 19.1 (17.4-20.8) 18.9 (17.2-20.6)
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CI indicates confidence interval; NR, not reported. 
a People aged ≥ 18 years. 
b Hawaii completed  of 12 months of interviews in 2004; these data are not available in the aggregate 2004 data set. 
c BRFSS does not report data if the sample size is fewer than 0 or CI is greater than 10. Consequently, prevalence estimates for some territories are not 
reported.
(Continued on next page)
State, District, Territory
With Disability Without Disability
Unadjusted 
% (95% CI)
Age-Adjusted 
% (95% CI)
Unadjusted 
% (95% CI)
Age-Adjusted 
% (95% CI)
Nebraska 24.0 (21.2-26.8) 29.4 (2.-.) 19. (18.2-20.8) 19.2 (17.9-20.)
Nevada 28. (2.1-.) 2.7 (26.2-9.2) 22. (19.8-24.8) 22.0 (19.6-24.4)
New Hampshire 28.6 (2.2-2.0) .1 (28.8-7.4) 20.0 (18.4-21.6) 19.6 (18.1-21.1)
New Jersey 2.2 (20.9-2.) 27. (24.-0.7) 18. (17.-19.) 18.1 (17.1-19.1)
New Mexico 24.4 (21.-27.) 28.6 (24.7-2.) 19.1 (17.7-20.) 18.7 (17.-20.1)
New York 2.1 (22.0-28.2) 28.9 (2.0-2.8) 18.8 (17.4-20.2) 18. (17.1-19.9)
North Carolina 26.4 (24.4-28.4) 0.8 (28.1-.) 22. (21.4-2.6) 21.8 (20.8-22.8)
North Dakota 18.9 (1.2-22.6) 27.8 (21.9-.7) 20.1 (18.2-22.0) 19.9 (18.0-21.8)
Ohio 1. (26.-6.) 8.0 (2.0-44.0) 24.7 (22.2-27.2) 24.4 (22.0-26.8)
Oklahoma 29.2 (26.6-1.8) 4.8 (1.-8.) 2. (2.8-26.8) 24.7 (2.2-26.2)
Oregon 2. (22.-28.) 0.0 (26.2-.8) 18. (16.8-19.8) 17.9 (16.4-19.4)
Pennsylvania 27.0 (24.1-29.9) 2.6 (28.7-6.) 21.9 (20.4-2.4) 22.0 (20.-2.)
Rhode Island 2. (20.0-27.0) 27.7 (22.8-2.6) 21.1 (19.1-2.1) 20.8 (18.9-22.7)
South Carolina 29.1 (26.1-2.1) 4.9 (1.0-8.8) 2. (21.8-24.8) 22.6 (21.2-24.0)
South Dakota 2.6 (22.-28.9) 1. (26.-6.) 19.4 (18.0-20.8) 19.2 (17.8-20.6)
Tennessee 1.6 (27.-.7) 4. (29.1-9.9) 24.7 (22.-26.9) 24.1 (22.0-26.2)
Texas 26.7 (2.4-0.0) 0.4 (26.-4.) 19. (17.9-20.7) 18. (17.1-19.9)
Utah 1.0 (12.2-17.8) 17. (1.9-20.7) 9. (8.4-10.6) 9.0 (8.0-10.0)
Vermont 24.6 (22.0-27.2) 29.4 (26.0-2.8) 18.8 (17.-20.1) 18. (17.2-19.8)
Virginia 2.0 (21.-28.) 0. (2.-.1) 20.2 (18.-21.9) 19.4 (17.8-21.0)
Washington 24.6 (2.0-26.2) 28. (26.4-0.6) 17.6 (16.7-18.) 16.9 (16.1-17.7)
West Virginia 29.7 (26.4-.0) 7.8 (.-42.) 2.7 (2.6-27.8) 2. (2.4-27.6)
Wisconsin 22.1 (18.6-2.6) 26.6 (22.1-1.1) 21.9 (20.2-2.6) 21.4 (19.7-2.1)
Wyoming 2.7 (22.-29.1) 29.6 (2.1-4.1) 21.0 (19.-22.7) 20.6 (19.0-22.2)
Puerto Rico 12. (9.2-1.4) 16. (11.9-21.1) 12.7 (11.1-14.) 12.2 (10.7-1.7)
District of Columbia 2. (18.0-28.6) 26.9 (20.7-.1) 20. (18.-22.7) 20.0 (17.9-22.1)
U.S. Virgin Islands NR NR 9.0 (7.-10.) 8.6 (7.2-10.0)
Median (49 States, DC, Territories) 2.1 29.9 20.2 19.8
 
CI indicates confidence interval; NR, not reported. 
a People aged ≥18 years. 
b Hawaii completed  of 12 months of interviews in 2004; these data are not available in the aggregate 2004 data set. 
c BRFSS does not report data if the sample size is fewer than 0 or CI is greater than 10. Consequently, prevalence estimates for some territories are not 
reported.
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Table 1. (continued) Smoking Prevalence Among Adults,a by Disability Status, Behavioral Risk Factor Surveillance System, 
49 States,b District of Columbia, Puerto Rico, and the U.S. Virgin Islands,c 2004
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Table 2. Age-Adjusted and Unadjusted Prevalence of Smoking Cessation Advice Among Adulta Current Smokers, by Disability 
Status, Behavioral Risk Factor Surveillance System, 20 Statesb, 2004
State
Age-Adjusted Prevalence Estimates
With Disability Without Disability
Had a Medical 
Encounter 
% (95% CI)
Received Quit 
Advice 
% (95% CI)
Discussed Tx 
Options 
% (95% CI)
Had a Medical 
Encounter 
% (95% CI)
Received Quit 
Advice 
% (95% CI)
Discussed Tx 
Options 
% (95% CI)
Arizona 9. (89.2-97.8) NR NR 78.6 (72.4-84.8) 6.8 (48.8-64.8) 4. (6.1-4.9)
Arkansas 86.2 (79.2-9.2) 62.2 (.8-70.6) NR 78. (74.9-82.1) 8.2 (.1-6.) 0. (4.7-7.)
Colorado 86.2 (79.-9.1) 82. (74.9-90.1) NR 69.8 (6.2-74.4) 69.6 (64.-74.9) 4.2 (47.-61.1)
Delaware 92.7 (88.4-97.0) 66.8 (6.9-76.7) NR 84.0 (80.1-87.9) 72.8 (67.8-77.8) 4.4 (47.7-61.1)
Iowa 88.1 (81.2-9.0) 69.9 (60.4-79.4) NR 7.4 (71.7-79.1) 8.7 (4.0-6.4) 0.9 (4.1-6.7)
Kentucky 87.0 (82.7-91.) 71.9 (6.2-78.6) 7.8 (49.-66.1) 66. (61.9-71.1) 68. (6.1-7.9) 6. (49.4-6.2)
Louisiana 80.0 (74.8-8.2) 67.0 (8.7-7.) .0 (44.0-62.0) 68.7 (6.7-71.7) 61.6 (7.7-6.) 0. (44.8-.8)
Montana 88.1 (82.2-94.0) 74. (67.8-81.2) NR 76.1 (71.7-80.) 6.6 (7.8-69.4) 48.2 (40.8-.6)
Nebraska 8.2 (79.7-90.7) 68.0 (60.-7.7) 62.9 (.2-72.6) 7.7 (70.4-77.0) 60.0 (.7-64.) 46. (40.-2.1)
New Jersey 89.4 (8.2-9.6) 7.0 (69.-80.7) . (46.8-6.8) 77.4 (74.6-80.2) 68.7 (6.4-72.0) 49.4 (4.4-.4)
New York 84.4 (78.2-90.6) 72.8 (6.0-80.6) 62.6 (.9-71.) 72.8 (68.9-76.7) 69. (64.9-7.7) . (47.9-9.1)
North Carolina 89. (86.-92.) 71.7 (66.7-76.7) 60. (4.1-66.9) 7.6 (71.2-76.0) 70. (67.7-7.) 9.7 (6.2-6.2)
North Dakota 86.9 (78.9-94.9) NR NR 71. (66.-76.) 9.6 (.-6.9) 49.9 (41.6-8.2)
Ohio 8.2 (76.0-94.4) 68.9 (9.1-78.7) NR 79.6 (74.6-84.6) 67.1 (60.4-7.8) 4.7 (7.-.9)
South Carolina 87. (81.4-9.2) 71.4 (6.2-77.6) 2.9 (44.4-61.4) 76.6 (7.4-79.8) 67. (6.4-71.2) 1.1 (46.0-6.2)
Texas 8.8 (80.6-91.0) 68.7 (60.9-76.) NR 66.0 (61.8-70.2) 8.8 (.8-6.8) 42.1 (.7-48.)
Virginia 92. (88.0-96.6) 70.1 (61.7-78.) 64.9 (.6-74.2) 78. (74.-82.) 66.7 (61.-71.9) 6.4 (49.4-6.4)
West Virginia 92.4 (89.1-9.7) 74.9 (68.-81.) 9.6 (0.8-68.4) 77.9 (7.6-82.2) 68. (6.1-7.) .8 (49.2-62.4)
Wisconsin 89.9 (8.7-96.1) 71.2 (62.-79.9) NR 7.6 (71.7-79.) 67.0 (61.9-72.1) 6. (9.4-71.6)
Wyoming 84.7 (77.9-91.) 6.9 (4.8-7.0) NR 69.8 (6.4-74.2) 6.6 (8.-68.9) 1. (44.-8.)
Medianc 87.2 70.7 9.6 7. 66.9 1.0
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CI indicates confidence interval; Tx, treatment; NR, not reported. 
a People aged ≥18 years. 
b BRFSS does not report data if the sample size is fewer than 0 or the confidence interval is greater than 10. Consequently, prevalence estimates for some 
states and the U.S. Virgin Islands are not reported. 
c If analysis is limited to states for which we are able to report estimates by disability status, age-adjusted median prevalences are 67.1% for people without 
disability who received advice to quit and .% for people without disability who discussed treatment options with their provider.
(Continued on next page)
State
Unadjusted Prevalence Estimates
With Disability Without Disability
Had a Medical 
Encounter % 
95% CI
Received Quit 
Advice 
% (95% CI)
Discussed Tx 
Options 
% (95% CI)
Had a Medical 
Encounter 
% (95% CI)
Received Quit 
Advice 
% (95% CI)
Discussed Tx 
Options 
% (95% CI)
Arizona 9.4 (89.2-97.6) NR NR 78. (72.-84.) 7.7 (49.-66.1) NR
Arkansas 87.9 (81.9-9.9) 62.9 (.6-70.2) 6.9 (47.0-66.8) 77.8 (74.0-81.6) 7.2 (2.0-62.4) 48.7 (41.8-.6)
Colorado 86. (80.2-92.8) 8. (76.4-90.2) NR 67.6 (62.7-72.) 70.1 (64.6-7.6) 2.8 (4.9-9.7)
Delaware 92.6 (88.-96.9) 68.1 (8.6-77.6) NR 8.8 (79.8-87.8) 70.7 (6.1-76.) .1 (48.1-62.1)
Iowa 88. (82.0-94.6) 71.4 (62.8-80.0) NR 74.0 (70.1-77.9) 9.1 (4.-6.9) 4.2 (48.0-60.4)
Kentucky 86.2 (81.7-90.7) 7. (67.0-79.6) 9.1 (1.-66.7) 6.9 (61.0-70.8) 69. (64.0-7.0) 7.9 (0.7-6.1)
Louisiana 79.1 (7.7-84.) 68.1 (60.4-7.8) 2.8 (44.8-60.8) 67.6 (64.-70.7) 60.6 (6.7-64.) 0.8 (4.4-6.2)
Montana 89.1 (84.2-94.0) 70.0 (62.7-77.) NR 7.0 (70.4-79.6) 6.8 (8.0-69.6) 49.4 (41.6-7.2)
Nebraska 86.1 (81.2-91.0) 69. (62.4-76.2) 62. (.6-71.4) 71.9 (68.2-7.6) 60.1 (.8-64.4) 46.9 (41.1-2.7)
New Jersey 89.0 (84.4-9.6) 7.2 (70.0-80.4) 6. (48.7-6.9) 76.7 (7.7-79.7) 68.1 (64.8-71.4) 49.8 (4.6-4.0)
New York 84.9 (78.9-90.9) 74.8 (67.-82.1) 62.2 (4.0-70.4) 72. (68.-76.) 68.8 (64.-7.) 4.2 (48.8-9.6)
North Carolina 89.0 (86.2-91.8) 74.0 (69.7-78.) 61.6 (6.2-67.0) 71. (68.6-74.0) 70.2 (67.2-7.2) 9. (.9-6.1)
North Dakota 88.0 (80.7-9.) NR NR 71.2 (66.1-76.) 9.1 (2.7-6.) 48. (40.-6.7)
Ohio 8.6 (7.8-9.4) 71.4 (62.-80.) NR 79. (74.4-84.2) 68.8 (62.2-7.4) 48.1 (9.-6.9)
South Carolina 86.9 (81.1-92.7) 72.2 (66.4-78.0) .7 (47.9-6.) 76.1 (72.8-79.4) 66.6 (62.4-70.8) 2.7 (47.-7.9)
Texas 8.7 (80.6-90.8) 69.8 (62.-77.1) NR 64.1 (9.8-68.4) 7.7 (2.6-62.8) 4.1 (6.-49.7)
Virginia 91.9 (87.7-96.1) 71.2 (6.-79.1) 64.8 (6.1-7.) 77.1 (72.8-81.4) 6.6 (60.-70.7) 7.4 (1.1-6.7)
West Virginia 91.8 (88.4-9.2) 7.4 (69.4-81.4) 61.0 (2.7-69.) 76.2 (71.8-80.6) 68.2 (6.1-7.) . (48.8-62.2)
Wisconsin 89.2 (82.8-9.6) 71. (62.9-79.7) NR 74.4 (70.4-78.4) 67.4 (62.4-72.4) 68.7 (62.9-74.)
Wyoming 8.7 (79.-92.1) 6.2 (6.8-7.6) 4.0 (44.0-64.0) 70. (66.-74.7) 6.1 (7.9-68.) 4.0 (47.1-60.9)
Medianc 88.0 71.4 9.1 74.2 66.1 2.8
 
CI indicates confidence interval; Tx, treatment; NR, not reported. 
a People aged ≥ 18 years. 
b BRFSS does not report data if the sample size is fewer than 0 or the confidence interval is greater than 10. Consequently, prevalence estimates for some 
states and the U.S. Virgin Islands are not reported. 
c If analysis is limited to states for which we are able to report estimates by disability status, age-adjusted median prevalences are 67.1% for people without 
disability who received advice to quit and .% for people without disability who discussed treatment options with their provider.
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Table 2. (continued) Age-Adjusted and Unadjusted Prevalence of Smoking Cessation Advice Among Adulta Current Smokers, 
by Disability Status, Behavioral Risk Factor Surveillance System, 20 Statesb, 2004
